The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hospital-Acquired Infections Assays Market Research Report 2024
Synopsis
Hospital-acquired infections assays refer to diagnostic tests and assays designed to identify and detect infections that patients may acquire during their stay in healthcare facilities, such as hospitals. These assays play a crucial role in early and accurate diagnosis, enabling healthcare providers to implement timely interventions and prevent the spread of infections within healthcare settings.
The global Hospital-Acquired Infections Assays market was valued at US$ 4070 million in 2023 and is anticipated to reach US$ 6670 million by 2030, witnessing a CAGR of 7.2% during the forecast period 2024-2030.
The market for hospital-acquired infections assays is driven by the increasing awareness of the importance of infection control in healthcare settings. The assays include a variety of diagnostic tools, such as molecular assays, immunoassays, and microbial culture tests, providing a comprehensive approach to identifying and managing hospital-acquired infections. The need for rapid and accurate diagnostics to reduce the incidence of hospital-acquired infections contributes to the growth of this market.
This report aims to provide a comprehensive presentation of the global market for Hospital-Acquired Infections Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital-Acquired Infections Assays.
Report Scope
The Hospital-Acquired Infections Assays market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hospital-Acquired Infections Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital-Acquired Infections Assays companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BIOMÉRIEUX
Abbott
F. Hoffmann-La Roche Ltd.
Siemens Healthcare Private Limited
BD (Becton, Dickinson and Company)
Bioscience, Inc.
QIAGEN
Thermo Fisher Scientific Inc.
Meridian Bioscience, Inc.
Hologic, Inc.
Segment by Type
Blood Tests
Urinalysis
Segment by Application
Urinary Tract Infections
Pneumonia
Surgical Site Infections
Bloodstream Infections
Other Hospital Infections
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hospital-Acquired Infections Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Hospital-acquired infections assays refer to diagnostic tests and assays designed to identify and detect infections that patients may acquire during their stay in healthcare facilities, such as hospitals. These assays play a crucial role in early and accurate diagnosis, enabling healthcare providers to implement timely interventions and prevent the spread of infections within healthcare settings.
The global Hospital-Acquired Infections Assays market was valued at US$ 4070 million in 2023 and is anticipated to reach US$ 6670 million by 2030, witnessing a CAGR of 7.2% during the forecast period 2024-2030.
The market for hospital-acquired infections assays is driven by the increasing awareness of the importance of infection control in healthcare settings. The assays include a variety of diagnostic tools, such as molecular assays, immunoassays, and microbial culture tests, providing a comprehensive approach to identifying and managing hospital-acquired infections. The need for rapid and accurate diagnostics to reduce the incidence of hospital-acquired infections contributes to the growth of this market.
This report aims to provide a comprehensive presentation of the global market for Hospital-Acquired Infections Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital-Acquired Infections Assays.
Report Scope
The Hospital-Acquired Infections Assays market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hospital-Acquired Infections Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital-Acquired Infections Assays companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BIOMÉRIEUX
Abbott
F. Hoffmann-La Roche Ltd.
Siemens Healthcare Private Limited
BD (Becton, Dickinson and Company)
Bioscience, Inc.
QIAGEN
Thermo Fisher Scientific Inc.
Meridian Bioscience, Inc.
Hologic, Inc.
Segment by Type
Blood Tests
Urinalysis
Segment by Application
Urinary Tract Infections
Pneumonia
Surgical Site Infections
Bloodstream Infections
Other Hospital Infections
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hospital-Acquired Infections Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital-Acquired Infections Assays Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Blood Tests
1.2.3 Urinalysis
1.3 Market by Application
1.3.1 Global Hospital-Acquired Infections Assays Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Urinary Tract Infections
1.3.3 Pneumonia
1.3.4 Surgical Site Infections
1.3.5 Bloodstream Infections
1.3.6 Other Hospital Infections
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hospital-Acquired Infections Assays Market Perspective (2019-2030)
2.2 Hospital-Acquired Infections Assays Growth Trends by Region
2.2.1 Global Hospital-Acquired Infections Assays Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hospital-Acquired Infections Assays Historic Market Size by Region (2019-2024)
2.2.3 Hospital-Acquired Infections Assays Forecasted Market Size by Region (2025-2030)
2.3 Hospital-Acquired Infections Assays Market Dynamics
2.3.1 Hospital-Acquired Infections Assays Industry Trends
2.3.2 Hospital-Acquired Infections Assays Market Drivers
2.3.3 Hospital-Acquired Infections Assays Market Challenges
2.3.4 Hospital-Acquired Infections Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital-Acquired Infections Assays Players by Revenue
3.1.1 Global Top Hospital-Acquired Infections Assays Players by Revenue (2019-2024)
3.1.2 Global Hospital-Acquired Infections Assays Revenue Market Share by Players (2019-2024)
3.2 Global Hospital-Acquired Infections Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital-Acquired Infections Assays Revenue
3.4 Global Hospital-Acquired Infections Assays Market Concentration Ratio
3.4.1 Global Hospital-Acquired Infections Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital-Acquired Infections Assays Revenue in 2023
3.5 Hospital-Acquired Infections Assays Key Players Head office and Area Served
3.6 Key Players Hospital-Acquired Infections Assays Product Solution and Service
3.7 Date of Enter into Hospital-Acquired Infections Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital-Acquired Infections Assays Breakdown Data by Type
4.1 Global Hospital-Acquired Infections Assays Historic Market Size by Type (2019-2024)
4.2 Global Hospital-Acquired Infections Assays Forecasted Market Size by Type (2025-2030)
5 Hospital-Acquired Infections Assays Breakdown Data by Application
5.1 Global Hospital-Acquired Infections Assays Historic Market Size by Application (2019-2024)
5.2 Global Hospital-Acquired Infections Assays Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hospital-Acquired Infections Assays Market Size (2019-2030)
6.2 North America Hospital-Acquired Infections Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hospital-Acquired Infections Assays Market Size by Country (2019-2024)
6.4 North America Hospital-Acquired Infections Assays Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hospital-Acquired Infections Assays Market Size (2019-2030)
7.2 Europe Hospital-Acquired Infections Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hospital-Acquired Infections Assays Market Size by Country (2019-2024)
7.4 Europe Hospital-Acquired Infections Assays Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital-Acquired Infections Assays Market Size (2019-2030)
8.2 Asia-Pacific Hospital-Acquired Infections Assays Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hospital-Acquired Infections Assays Market Size by Region (2019-2024)
8.4 Asia-Pacific Hospital-Acquired Infections Assays Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hospital-Acquired Infections Assays Market Size (2019-2030)
9.2 Latin America Hospital-Acquired Infections Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hospital-Acquired Infections Assays Market Size by Country (2019-2024)
9.4 Latin America Hospital-Acquired Infections Assays Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital-Acquired Infections Assays Market Size (2019-2030)
10.2 Middle East & Africa Hospital-Acquired Infections Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hospital-Acquired Infections Assays Market Size by Country (2019-2024)
10.4 Middle East & Africa Hospital-Acquired Infections Assays Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BIOMÉRIEUX
11.1.1 BIOMÉRIEUX Company Detail
11.1.2 BIOMÉRIEUX Business Overview
11.1.3 BIOMÉRIEUX Hospital-Acquired Infections Assays Introduction
11.1.4 BIOMÉRIEUX Revenue in Hospital-Acquired Infections Assays Business (2019-2024)
11.1.5 BIOMÉRIEUX Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Hospital-Acquired Infections Assays Introduction
11.2.4 Abbott Revenue in Hospital-Acquired Infections Assays Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Company Detail
11.3.2 F. Hoffmann-La Roche Ltd. Business Overview
11.3.3 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Introduction
11.3.4 F. Hoffmann-La Roche Ltd. Revenue in Hospital-Acquired Infections Assays Business (2019-2024)
11.3.5 F. Hoffmann-La Roche Ltd. Recent Development
11.4 Siemens Healthcare Private Limited
11.4.1 Siemens Healthcare Private Limited Company Detail
11.4.2 Siemens Healthcare Private Limited Business Overview
11.4.3 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Introduction
11.4.4 Siemens Healthcare Private Limited Revenue in Hospital-Acquired Infections Assays Business (2019-2024)
11.4.5 Siemens Healthcare Private Limited Recent Development
11.5 BD (Becton, Dickinson and Company)
11.5.1 BD (Becton, Dickinson and Company) Company Detail
11.5.2 BD (Becton, Dickinson and Company) Business Overview
11.5.3 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Introduction
11.5.4 BD (Becton, Dickinson and Company) Revenue in Hospital-Acquired Infections Assays Business (2019-2024)
11.5.5 BD (Becton, Dickinson and Company) Recent Development
11.6 Bioscience, Inc.
11.6.1 Bioscience, Inc. Company Detail
11.6.2 Bioscience, Inc. Business Overview
11.6.3 Bioscience, Inc. Hospital-Acquired Infections Assays Introduction
11.6.4 Bioscience, Inc. Revenue in Hospital-Acquired Infections Assays Business (2019-2024)
11.6.5 Bioscience, Inc. Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Detail
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN Hospital-Acquired Infections Assays Introduction
11.7.4 QIAGEN Revenue in Hospital-Acquired Infections Assays Business (2019-2024)
11.7.5 QIAGEN Recent Development
11.8 Thermo Fisher Scientific Inc.
11.8.1 Thermo Fisher Scientific Inc. Company Detail
11.8.2 Thermo Fisher Scientific Inc. Business Overview
11.8.3 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Introduction
11.8.4 Thermo Fisher Scientific Inc. Revenue in Hospital-Acquired Infections Assays Business (2019-2024)
11.8.5 Thermo Fisher Scientific Inc. Recent Development
11.9 Meridian Bioscience, Inc.
11.9.1 Meridian Bioscience, Inc. Company Detail
11.9.2 Meridian Bioscience, Inc. Business Overview
11.9.3 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Introduction
11.9.4 Meridian Bioscience, Inc. Revenue in Hospital-Acquired Infections Assays Business (2019-2024)
11.9.5 Meridian Bioscience, Inc. Recent Development
11.10 Hologic, Inc.
11.10.1 Hologic, Inc. Company Detail
11.10.2 Hologic, Inc. Business Overview
11.10.3 Hologic, Inc. Hospital-Acquired Infections Assays Introduction
11.10.4 Hologic, Inc. Revenue in Hospital-Acquired Infections Assays Business (2019-2024)
11.10.5 Hologic, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
